Historical record - last NADAC publication: 12/22/2017
Product Information
KALETRA 80 MG-20 MG/ML SOLN is a brand product labeled by AbbVie Inc., priced at $3.1186 per ML under NDC 00074395646. Its NADAC has been published 264 times since Nov 28, 2013.
Strength
80; 20 mg/mL; mg/mL
Manufacturer
AbbVie Inc.NDC
00074395646
Classification
Brand
Dosage Form
SOLUTION
Route
ORAL
Last Updated
12/22/2017
Active Ingredients
LOPINAVIR; RITONAVIRApproval Type
New Drug (NDA)
FDA Application
NDA021251On Market Since
6/18/2010
Pharmacological Classes
Price Statistics
The NADAC for KALETRA 80 MG-20 MG/ML SOLN has been published 264 times since Nov 28, 2013, and over the history we have for it it has risen 31.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.1186 per ML |
|---|---|
| All-time high | $3.1186 (Dec 12, 2018) |
| All-time low | $2.3689 (Nov 28, 2013) |
| Median price | $2.8073 |
| Average price | $2.7693 |
| Largest weekly change | +6.9% (Jan 6, 2016) |
| Weeks tracked | 264 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Lopinavir and Ritonavir market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of KALETRA 80 MG-20 MG/ML SOLN?
The current National Average Drug Acquisition Cost (NADAC) for KALETRA 80 MG-20 MG/ML SOLN, manufactured by AbbVie Inc., is $3.1186 per ML (NDC 00074395646), effective Dec 12, 2018.
How has the price of KALETRA 80 MG-20 MG/ML SOLN changed over time?
Over the history we have for it, the NADAC for KALETRA 80 MG-20 MG/ML SOLN has risen 31.6%. It has been tracked across 264 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KALETRA 80 MG-20 MG/ML SOLN?
Since Nov 28, 2013, the NADAC for KALETRA 80 MG-20 MG/ML SOLN has ranged from a low of $2.3689 (Nov 28, 2013) to a high of $3.1186 (Dec 12, 2018), with a median of $2.8073 per ML.
Are there cheaper alternatives to KALETRA 80 MG-20 MG/ML SOLN?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of KALETRA 80 MG-20 MG/ML SOLN, so no direct lower-cost alternative is listed.
Who manufactures KALETRA 80 MG-20 MG/ML SOLN?
KALETRA 80 MG-20 MG/ML SOLN (NDC 00074395646) is labeled by AbbVie Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification